OPKO Health (OPK) Tops Q2 EPS by 4c, beats revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts OPK Hot Sheet
Price: $1.63 --0%
EPS Growth %: -333.3%
Financial Fact:
Product sales: 20.57M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: -333.3%
Financial Fact:
Product sales: 20.57M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
OPKO Health (NASDAQ: OPK) reported Q2 EPS of ($0.03), $0.04 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $265.4 million versus the consensus estimate of $201.97 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- AI-powered cyber threats light a fire under cybersecurity stocks
- Caldwell sells IQTalent subsidiary to WinMil for C$4.7M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
